Pharmacokinetics, Metabolism, and Routes of Excretion of Intravenous Irofulven in Patients with Advanced Solid Tumors-Reference-Cited by-同舟云学术

Pharmacokinetics, Metabolism, and Routes of Excretion of Intravenous Irofulven in Patients with Advanced Solid Tumors

Published:2006-08-08 Issue:11 Volume:34 Page:1918-1926
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Paci Angelo,Rezai Keyvan,Deroussent Alain,De Valeriola Dominique,Re Micheline,Weill Sophie,Cvitkovic Esteban,Kahatt Carmen,Shah Ajit,Waters Stephen,Weems Gary,Vassal Gilles,Lokiec François

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference15 articles.

1. Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients

2. NADPH Alkenal/One Oxidoreductase Activity Determines Sensitivity of Cancer Cells to the Chemotherapeutic Alkylating Agent Irofulven

3. Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

4. Discovery and development of sesquiterpenoid derived hydroxymethylacylfulvene: a new anticancer drug

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023

2. Secondary Metabolites of Basidiomycetes;Physiology and Genetics;2018

3. Secondary Metabolites from Higher Fungi;Progress in the Chemistry of Organic Natural Products 106;2017

4. Irofulven;Handbook of Metabolic Pathways of Xenobiotics;2013-10-13

5. Bioanalytical aspects of clinical mass balance studies in oncology;Bioanalysis;2011-12